Agus Roy Rusly Hariantana Hamid
Research Subjects
Agus Roy Rusly Hariantana Hamid has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- I Gusti Putu Hendra Sanjaya
RSUP Ngoerah
5 shared publications - I Gusti Ayu Sri Mahendra Dewi
RSUP Ngoerah
2 shared publications - Putu Anda Tusta Adiputra
RSUP Ngoerah
2 shared publications - Rosalyn Devina Santoso
Department of Plastic Reconstruction and Aesthetics, Prof. Dr. I.G.N.G Ngoerah Hospital, Bali, Indonesia
2 shared publications - Sianny Herawati
Department of Clinical Pathology, Faculty of Medicine, Universitas Udayana, Bali, Denpasar 80232, Indonesia
2 shared publications - Tjokorda Gde Bagus Mahadewa
Department of Neurosurgery, Universitas Udayana, Prof. I.G.N.G Ngoerah General Hospital, Bali, Indonesia
2 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by Green Publisher in Eduvest - Journal of Universal Studies
- Vol. 5 (10) , 12436-12444
Probiotics and Vitamin D for Gastrointestinal Damage in Burn Injury
Curling’s ulcer, a stress-induced gastrointestinal injury, commonly occurs in patients with major burns due to ischemia and mucosal necrosis. Complications may include perforation, hemorrhagic shock, and death. While standard treatments involve PPIs, sucralfate, and early enteral feeding, probiotics may help restore gut microbiota, and vitamin D can reduce inflammation and dysbiosis. However, studies on their combined efficacy remain limited, particularly in Indonesia. This research aims to evaluate whether oral probiotics and vitamin D reduce TNF-α levels and gastrointestinal damage in Wistar rats with major burns. The study employed an experimental design using 32 Wistar rats with 25% TBSA burns. Subjects were divided into four groups: control (K), probiotics only (P1), vitamin D only (P2), and probiotics + vitamin D (P3). Interventions were administered for two weeks. Measured parameters included blood and tissue TNF-α levels, as well as gastric and intestinal histopathology. Data were analyzed using SPSS. Results showed that group P3 had the lowest tissue TNF-α levels (136.11 ± 50.14; p = 0.046) and intestinal mucosal thickness (914.54 ± 170.08; p = 0.007). Indicators of gastric damage—macrophage count, necrosis, and bleeding—were significantly reduced in the treatment groups (p = 0.000). No significant difference was observed in villi width (p = 0.974). Combined oral probiotics and vitamin D significantly reduced tissue TNF-α levels and gastrointestinal damage, with better outcomes than single-agent treatments. This combination therapy shows potential as an adjunctive approach for gastrointestinal protection in major burns.
- 1 October 2025
- Published by Green Publisher in Eduvest - Journal of Universal Studies
- Vol. 5 (10) , 12436-12444
Open AccessProbiotics and Vitamin D for Gastrointestinal Damage in Burn Injury
Curling’s ulcer, a stress-induced gastrointestinal injury, commonly occurs in patients with major burns due to ischemia and mucosal necrosis. Complications may include perforation, hemorrhagic shock, and death. While standard treatments involve PPIs, sucralfate, and early enteral feeding, probiotics may help restore gut microbiota, and vitamin D can reduce inflammation and dysbiosis. However, studies on their combined efficacy remain limited, particularly in Indonesia. This research aims to evaluate whether oral probiotics and vitamin D reduce TNF-α levels and gastrointestinal damage in Wistar rats with major burns. The study employed an experimental design using 32 Wistar rats with 25% TBSA burns. Subjects were divided into four groups: control (K), probiotics only (P1), vitamin D only (P2), and probiotics + vitamin D (P3). Interventions were administered for two weeks. Measured parameters included blood and tissue TNF-α levels, as well as gastric and intestinal histopathology. Data were analyzed using SPSS. Results showed that group P3 had the lowest tissue TNF-α levels (136.11 ± 50.14; p = 0.046) and intestinal mucosal thickness (914.54 ± 170.08; p = 0.007). Indicators of gastric damage—macrophage count, necrosis, and bleeding—were significantly reduced in the treatment groups (p = 0.000). No significant difference was observed in villi width (p = 0.974). Combined oral probiotics and vitamin D significantly reduced tissue TNF-α levels and gastrointestinal damage, with better outcomes than single-agent treatments. This combination therapy shows potential as an adjunctive approach for gastrointestinal protection in major burns.
- Open Access
- 3 September 2025
- Published by Green Publisher in Eduvest - Journal of Universal Studies
- Vol. 5 (9) , 11378-11386
Purple Sweet Potato Extract Effects On Tnf-Α And Gut Injury
The purpose of this study was to evaluate the effect of oral administration of purple sweet potato (Ipomoea batatas L.) extract on serum and tissue TNF-α levels in the gaster and duodenum, as well as on gastrointestinal damage in Wistar rats (Rattus norvegicus) with major burns. This experimental research used a Randomized Post-Test Only Control Group Design with Wistar rats as subjects, divided into a control group (P0) and a treatment group (P1). The results showed that serum TNF-α levels were significantly lower in the treatment group compared to the control group (p = 0.002). Tissue TNF-α levels also decreased significantly (p = 0.049), suggesting a local anti-inflammatory effect on the intestinal mucosa. Statistical analysis demonstrated that mucosal thickness was higher in the treatment group, with a mean difference of 270.32 µm (p < 0.001). However, there was no significant difference in villi width between groups (p = 0.129). Significant differences were observed in mucosal necrosis lesions (p < 0.001), hemorrhage lesions (p < 0.001), and inflammation lesions (p = 0.001) between the treatment and control groups. In conclusion, oral administration of purple sweet potato extract effectively reduced serum and tissue TNF-α levels, increased intestinal mucosal thickness, and protected against mucosal damage in rats with major burns. These findings indicate the potential of purple sweet potato extract as an adjuvant therapy to reduce systemic inflammation and improve intestinal mucosal integrity in burn conditions.
- 3 September 2025
- Published by Green Publisher in Eduvest - Journal of Universal Studies
- Vol. 5 (9) , 11378-11386
Open AccessPurple Sweet Potato Extract Effects On Tnf-Α And Gut Injury
The purpose of this study was to evaluate the effect of oral administration of purple sweet potato (Ipomoea batatas L.) extract on serum and tissue TNF-α levels in the gaster and duodenum, as well as on gastrointestinal damage in Wistar rats (Rattus norvegicus) with major burns. This experimental research used a Randomized Post-Test Only Control Group Design with Wistar rats as subjects, divided into a control group (P0) and a treatment group (P1). The results showed that serum TNF-α levels were significantly lower in the treatment group compared to the control group (p = 0.002). Tissue TNF-α levels also decreased significantly (p = 0.049), suggesting a local anti-inflammatory effect on the intestinal mucosa. Statistical analysis demonstrated that mucosal thickness was higher in the treatment group, with a mean difference of 270.32 µm (p < 0.001). However, there was no significant difference in villi width between groups (p = 0.129). Significant differences were observed in mucosal necrosis lesions (p < 0.001), hemorrhage lesions (p < 0.001), and inflammation lesions (p = 0.001) between the treatment and control groups. In conclusion, oral administration of purple sweet potato extract effectively reduced serum and tissue TNF-α levels, increased intestinal mucosal thickness, and protected against mucosal damage in rats with major burns. These findings indicate the potential of purple sweet potato extract as an adjuvant therapy to reduce systemic inflammation and improve intestinal mucosal integrity in burn conditions.
- Open Access
- 9 July 2023
- Published by DiscoverSys, Inc. in Indonesia Journal of Biomedical Science
- Vol. 17 (2) , 206-210
An anterolateral thigh free flap for reconstruction of extensive neck defect in diabetic patient: a case report
Introduction: Reconstruction of the head and neck has challenges due to its three-dimensional structure, tissue complexity, extent of the defect, and clinical scenarios. Advances in microsurgical techniques make free tissue transfer reconstruction a popular choice to address these issues. Anterolateral thigh perforator flap (ALT) is a workhorse flap for head and neck reconstruction due to its long and reliable pedicle, large volume, versatility in composition, and low donor morbidity. However, diabetes mellitus may contribute to developing postoperative complications, such as vascular occlusions and thrombosis, that endanger free flap survival and are associated with poor wound healing. This case report demonstrates the successful utilization of this approach in the closure of extensive neck defects in a diabetic patient. Case Presentation: A 56-year-old male was referred with a 21 cm x 15 cm defect following an odontogenic submandibular abscess. The flaw was extended from the intrabuccal, neck, and one-third of the upper anterior thorax, involving the skin, subcutaneous tissue, and exposed mandibular bone. The patient had previously uncontrolled diabetes mellitus. Surgical debridement, antibiotics, insulin for glucose control, and wound bed preparation were performed. A free fasciocutaneous ALT flap was used for defect closure. The flap was raised template-based, sized 24 × 15 cm, with a pedicle from the descending branch of a lateral circumflex femoral vessel. End-to-end anastomosis of one artery and vein of the superior thyroid vessel was performed. The donor site was closed using a split-thickness skin graft. The surgery and recovery were uneventful. Flap refinement was carried out one month later. The patient underwent a three-month follow-up period, expressing satisfaction with the aesthetic and functional outcomes. Conclusions: Anterolateral thigh perforator flap (ALT) is a workhorse flap for reconstruction of head and neck reconstruction due to its long and reliable pedicle, large tissue volume with various compositions, and low donor morbidity. The LD flap presents as an alternative for free tissue transfer. Regional pedicled flaps can be chosen where microsurgery is not available or suitable. However, vascular compromise and flap failure remain a challenge. Identifying and managing risk factors such as diabetes mellitus are needed to minimize significant complications.
- 9 July 2023
- Published by DiscoverSys, Inc. in Indonesia Journal of Biomedical Science
- Vol. 17 (2) , 206-210
Open AccessAn anterolateral thigh free flap for reconstruction of extensive neck defect in diabetic patient: a case report
Introduction: Reconstruction of the head and neck has challenges due to its three-dimensional structure, tissue complexity, extent of the defect, and clinical scenarios. Advances in microsurgical techniques make free tissue transfer reconstruction a popular choice to address these issues. Anterolateral thigh perforator flap (ALT) is a workhorse flap for head and neck reconstruction due to its long and reliable pedicle, large volume, versatility in composition, and low donor morbidity. However, diabetes mellitus may contribute to developing postoperative complications, such as vascular occlusions and thrombosis, that endanger free flap survival and are associated with poor wound healing. This case report demonstrates the successful utilization of this approach in the closure of extensive neck defects in a diabetic patient. Case Presentation: A 56-year-old male was referred with a 21 cm x 15 cm defect following an odontogenic submandibular abscess. The flaw was extended from the intrabuccal, neck, and one-third of the upper anterior thorax, involving the skin, subcutaneous tissue, and exposed mandibular bone. The patient had previously uncontrolled diabetes mellitus. Surgical debridement, antibiotics, insulin for glucose control, and wound bed preparation were performed. A free fasciocutaneous ALT flap was used for defect closure. The flap was raised template-based, sized 24 × 15 cm, with a pedicle from the descending branch of a lateral circumflex femoral vessel. End-to-end anastomosis of one artery and vein of the superior thyroid vessel was performed. The donor site was closed using a split-thickness skin graft. The surgery and recovery were uneventful. Flap refinement was carried out one month later. The patient underwent a three-month follow-up period, expressing satisfaction with the aesthetic and functional outcomes. Conclusions: Anterolateral thigh perforator flap (ALT) is a workhorse flap for reconstruction of head and neck reconstruction due to its long and reliable pedicle, large tissue volume with various compositions, and low donor morbidity. The LD flap presents as an alternative for free tissue transfer. Regional pedicled flaps can be chosen where microsurgery is not available or suitable. However, vascular compromise and flap failure remain a challenge. Identifying and managing risk factors such as diabetes mellitus are needed to minimize significant complications.
- Open Access
- 16 May 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (3) , 2981-2985
Ascorbic acid and calcitriol reduce TNF-α to improve the viability of modified McFarlane random skin flaps in Wistar rats
Link of Video https://youtu.be/8UIEdUv8za8 Introduction: Distal flap necrosis is one of the most common complications in flap procedure. Ascorbic acid (vitamin C) is one of the most widespread antioxidants available, while calcitriol, a metabolite of vitamin D, has anti-inflammatory and antioxidant properties. The purpose of this study was to determine the effect of ascorbic acid and calcitriol on the viability of Modified McFarlane random skin flaps in Wistar rats and its mechanism through suppression of proinflammatory cytokine Tumor Necrosis Factor-α (TNF-α). Methods: An experimental study used 28 Wistar rats, by creating a caudally based 3 cm x 9 cm Modified McFarlane random skin flap and divided into four groups. The first group was injected with 200 mg/kg/day ascorbic acid, the second group with 2μg/kg/day calcitriol, and the third group with 200 mg/kg/day ascorbic acid combined with 2μg/kg/day calcitriol was injected two hours after flap elevation for seven days, respectively. The control group was not given any intraperitoneal injection. After seven days, the percentage of flap viability rate was measured and tissue sampling was performed to measure the amount of capillary density and TNF-α in all groups. Results: The higher percentage of viable flap area was found in all treatment groups, the highest in the ascorbic acid group 80.63% (p<0.001). The highest capillary density was found in ascorbic acid combined with the calcitriol group (27/visual field, p<0.001) compared to all groups. It was also found that the amount of TNF-α in the tissue was lowest in the group administered by ascorbic acid combined with calcitriol compared to all groups 57.38 ng/L and 0.62 nmol/mL respectively compared to all groups (p<0.001). The higher percentage of viable flap area was correlated with a lower amount of TNF-α (p0.05). Conclusion: Ascorbic acid in combination with calcitriol improves the viability of Modified McFarlane random skin flaps by lowering TNF-α levels.
- 16 May 2023
- Published by DiscoverSys, Inc. in Bali Medical Journal
- Vol. 12 (3) , 2981-2985
Open AccessAscorbic acid and calcitriol reduce TNF-α to improve the viability of modified McFarlane random skin flaps in Wistar rats
Link of Video https://youtu.be/8UIEdUv8za8 Introduction: Distal flap necrosis is one of the most common complications in flap procedure. Ascorbic acid (vitamin C) is one of the most widespread antioxidants available, while calcitriol, a metabolite of vitamin D, has anti-inflammatory and antioxidant properties. The purpose of this study was to determine the effect of ascorbic acid and calcitriol on the viability of Modified McFarlane random skin flaps in Wistar rats and its mechanism through suppression of proinflammatory cytokine Tumor Necrosis Factor-α (TNF-α). Methods: An experimental study used 28 Wistar rats, by creating a caudally based 3 cm x 9 cm Modified McFarlane random skin flap and divided into four groups. The first group was injected with 200 mg/kg/day ascorbic acid, the second group with 2μg/kg/day calcitriol, and the third group with 200 mg/kg/day ascorbic acid combined with 2μg/kg/day calcitriol was injected two hours after flap elevation for seven days, respectively. The control group was not given any intraperitoneal injection. After seven days, the percentage of flap viability rate was measured and tissue sampling was performed to measure the amount of capillary density and TNF-α in all groups. Results: The higher percentage of viable flap area was found in all treatment groups, the highest in the ascorbic acid group 80.63% (p<0.001). The highest capillary density was found in ascorbic acid combined with the calcitriol group (27/visual field, p<0.001) compared to all groups. It was also found that the amount of TNF-α in the tissue was lowest in the group administered by ascorbic acid combined with calcitriol compared to all groups 57.38 ng/L and 0.62 nmol/mL respectively compared to all groups (p<0.001). The higher percentage of viable flap area was correlated with a lower amount of TNF-α (p0.05). Conclusion: Ascorbic acid in combination with calcitriol improves the viability of Modified McFarlane random skin flaps by lowering TNF-α levels.
- Open Access
- 10 November 2022
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- p. 48435-48451
Administration of botulinum toxin a and vascular endhotelial growth factor reduce norepinephrine levels and increase viability of modified mcfarlane flap in wistar rat
Local hyperadrenergic states after a random flap elevation mediated by humoral vasoconstrictors can lead to flap necrosis. This study aimed to evaluate the effect of Botulinum Toxin A (BoNT-A) on reducing levels of Norepinephrine (NE) as the main humoral vasoactive substance, as well as its additive effect with Vascular Endothelial Growth Factor (VEGF) in increasing the viability of random flap. 28 Wistar Rats with Caudally Based Modified McFarlane Flap were divided into four groups. Group I received BoNT-A 3 days before flap elevation, group II received VEGF immediately after flap elevation, group III received a combination of BoNT-A and VEGF, group IV was a control group. Result in this study NE levels lowest was found in the BoNT-A+VEGF combination group (94.63 ± 5 .25 ng/ml, p<0.05 in group I, p<0.01 in groups II and IV). The highest value of FVR was shown in the BoNT-A+VEGF combination group (93.37 ± 2.19 %, p < 0.05 in group I, p < 0.01 in groups II and IV). Meanwhile, the increase in flap viability in the VEGF group was not statistically significant. So Conclusion administration of BoNT-A in combination with VEGF can increase the viability of random flaps by decreasing NE levels.
- 10 November 2022
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- p. 48435-48451
Open AccessAdministration of botulinum toxin a and vascular endhotelial growth factor reduce norepinephrine levels and increase viability of modified mcfarlane flap in wistar rat
Local hyperadrenergic states after a random flap elevation mediated by humoral vasoconstrictors can lead to flap necrosis. This study aimed to evaluate the effect of Botulinum Toxin A (BoNT-A) on reducing levels of Norepinephrine (NE) as the main humoral vasoactive substance, as well as its additive effect with Vascular Endothelial Growth Factor (VEGF) in increasing the viability of random flap. 28 Wistar Rats with Caudally Based Modified McFarlane Flap were divided into four groups. Group I received BoNT-A 3 days before flap elevation, group II received VEGF immediately after flap elevation, group III received a combination of BoNT-A and VEGF, group IV was a control group. Result in this study NE levels lowest was found in the BoNT-A+VEGF combination group (94.63 ± 5 .25 ng/ml, p<0.05 in group I, p<0.01 in groups II and IV). The highest value of FVR was shown in the BoNT-A+VEGF combination group (93.37 ± 2.19 %, p < 0.05 in group I, p < 0.01 in groups II and IV). Meanwhile, the increase in flap viability in the VEGF group was not statistically significant. So Conclusion administration of BoNT-A in combination with VEGF can increase the viability of random flaps by decreasing NE levels.